Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Leukemia

Free Subscription 13.04.2026 1 Acta Haematol 2 Am J Clin Pathol 2 Am J Hematol 3 Ann Hematol 5 Blood 2 Bone Marrow Transplant 4 Cancer 2 Eur J Haematol 1 Int J Hematol 1 J Clin Oncol 1 J Natl Cancer Inst 1 Leuk Lymphoma 1 Leukemia 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Haematol

1. ABDULGAYOOM M, Afana MS, Haj Saleh L, Manthiri AA, et al
   Venetoclax-Based Regimens in Chronic Myelomonocytic Leukemia: A Systematic Review and Meta-Analysis.
   Acta Haematol. 2026 Apr 7:1-25. doi: 10.1159/000551885.
   PubMed         Abstract available
   
   

   
   Am J Clin Pathol

2. KARUBE K
   Highly sensitive HBZ RNA in situ hybridization enables routine pathologic diagnosis of adult T-cell leukemia/lymphoma.
   Am J Clin Pathol. 2026;165:aqag022.
   PubMed        
   
   
3. SAFT L, Tzankov A, Traverse-Glehen A, Green A, et al
   Myeloid/lymphoid precursor cell neoplasms and mixed phenotype acute leukemias: A Bone Marrow Workshop Report from the 22nd European Association for Hematopathology/Society of Hematopathology Meeting, Dubrovnik, 2024.
   Am J Clin Pathol. 2026;165:aqag019.
   PubMed         Abstract available
   
   

   
   Am J Hematol

4. HUANG J, Huang H, Zhang Y, Xia Y, et al
   Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFbeta::MYH11 Fusions.
   Am J Hematol. 2026;101:972-985.
   PubMed         Abstract available
   
   
5. ASPAS REQUENA G, Montesinos P, Berard E, Bertoli S, et al
   Intensive Chemotherapy With or Without Midostaurin in Adults >/= 60 Years Old With FLT3-Mutated AML: A FILO-DATAML-PETHEMA Real-World Study.
   Am J Hematol. 2026;101:949-960.
   PubMed         Abstract available
   
   

   
   Ann Hematol

6. JAGER P, Ralfs AA, Schulz F, Liebers N, et al
   Impact of early tacrolimus exposure on outcomes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes.
   Ann Hematol. 2026;105:232.
   PubMed         Abstract available
   
   
7. LEUNG GMK, Ye Y, Luo Y, Shi J, et al
   A novel prognostic scoring system HATS for acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation.
   Ann Hematol. 2026;105:228.
   PubMed        
   
   
8. PERRONE S, Pacitto G, Tirnetta A, Mulargia C, et al
   A case of T-prolymphocytic leukemia harboring RAS mutation.
   Ann Hematol. 2026;105:230.
   PubMed        
   
   

   
   Blood

9. TORIBIO ML, Garcia-Leon MJ, Garcia-Peydro M, Fuentes P, et al
   A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia.
   Blood. 2026 Apr 8:blood.2025030670. doi: 10.1182/blood.2025030670.
   PubMed         Abstract available
   
   
10. SUZUKI Y, Nakajima-Takagi Y, Oshima M, Ochi Y, et al
    Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.
    Blood. 2026 Apr 8:blood.2025032083. doi: 10.1182/blood.2025032083.
    PubMed         Abstract available
    
    
11. LAU IJ, Bloye G, Smith AL, Harman J, et al
    MYB activity drives emergent enhancer activation and enhancer-promoter interactions in acute lymphoblastic leukemia.
    Blood. 2026 Mar 19:blood.2025030424. doi: 10.1182/blood.2025030424.
    PubMed         Abstract available
    
    
12. SCHIMMER RR, Klemm N, Fullin J, Topcu E, et al
    Bone marrow failure, somatic rescue by p53 inactivation, and enhanced leukemogenesis in germ line ERCC6L2 disease.
    Blood. 2026;147:1663-1679.
    PubMed         Abstract available
    
    
13. ITSARA A, Rogness VM, Samples L, Yuan CM, et al
    A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study.
    Blood. 2026;147:1702-1712.
    PubMed         Abstract available
    
    

    
    Bone Marrow Transplant

14. VON ASMUTH EGJ, Halkes CJM, Versluis J, Eikema DA, et al
    An extraction pipeline for analysis of hematopoietic stem cell transplantation data.
    Bone Marrow Transplant. 2026 Mar 10. doi: 10.1038/s41409-026-02818.
    PubMed         Abstract available
    
    
15. ALONSO-SALADRIGUES A, Esperanza-Cebollada E, Vicente-Garces C, Perez-Jaume S, et al
    Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.
    Bone Marrow Transplant. 2026 Apr 4. doi: 10.1038/s41409-026-02838.
    PubMed         Abstract available
    
    

    
    Cancer

16. DANILOV AV, Coombs CC, Phillips T, Allan JN, et al
    Clinical strategies for lymphoma management: Recommendations from the Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Consensus Conference 2025.
    Cancer. 2026;132:e70389.
    PubMed         Abstract available
    
    
17. KANTARJIAN H, Qiao W, Jain N, Jen WY, et al
    Outcome of second-line therapy in adult B-cell acute lymphoblastic leukemia.
    Cancer. 2026;132:e70401.
    PubMed         Abstract available
    
    
18. FRIEND R, Johnson PC, Campbell D, Rosko AE, et al
    Beyond age: Frailty-guided care in hematologic malignancies.
    Cancer. 2026;132:e70375.
    PubMed         Abstract available
    
    
19. KISHIMOTO K, Nakata K, Kato MS, Ikawa T, et al
    Increasing incidence and changing distribution of primary cancers in therapy-related acute myeloid leukemia: A population-based study in Osaka, Japan, 1990-2020.
    Cancer. 2026;132:e70316.
    PubMed         Abstract available
    
    

    
    Eur J Haematol

20. ISHIKAWA C, Mori N
    Role of Nek2 and Hec1 in HTLV-1-Infected T-Cell Lines.
    Eur J Haematol. 2026;116:635-645.
    PubMed         Abstract available
    
    
21. WU N, Kong J, Lv M, Mo XD, et al
    Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and Survival.
    Eur J Haematol. 2026;116:615-624.
    PubMed         Abstract available
    
    

    
    Int J Hematol

22. TAZOE K, Nakamae H, Makuuchi Y, Kuno M, et al
    Ten-color multicolor flow cytometry-based measurable residual disease at pre-transplantation predicts relapse of acute myeloid leukemia: a prospective study.
    Int J Hematol. 2026 Apr 7. doi: 10.1007/s12185-026-04207.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

23. RETTINGER E, Heckl D, Hutter M, Salzmann-Manrique E, et al
    First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.
    J Clin Oncol. 2026 Apr 6:JCO2501966. doi: 10.1200/JCO-25-01966.
    PubMed         Abstract available
    
    

    
    J Natl Cancer Inst

24. PAHNKE S, Alcala K, Bulos Salim C, Cortez Cardoso Penha R, et al
    Lymphocyte count and risk of chronic lymphocytic leukemia.
    J Natl Cancer Inst. 2026;118:636-642.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

25. MOHTY R, Narra R, Mims AS, Hunter C, et al
    Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignan
    Leuk Lymphoma. 2026 Apr 9:1-8. doi: 10.1080/10428194.2026.2650679.
    PubMed         Abstract available
    
    

    
    Leukemia

26. SAJIKI D, Muramatsu H, Wakamatsu M, Tsumura Y, et al
    Error-corrected next-generation sequencing for profiling the subclonal genetic architecture of juvenile myelomonocytic leukemia.
    Leukemia. 2026 Apr 7. doi: 10.1038/s41375-026-02922.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

27. TANG S, Zong L, Ma S, Shang Y, et al
    Structure-guided design of 7-azaindole DNMT1 inhibitors active against hypomethylating agent-resistant acute myeloid leukemia.
    Proc Natl Acad Sci U S A. 2026;123:e2532472123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum